Mydecine is tapping into the spiritual dimension of psychedelics with its own meditation app.
Exploring the companies and themes that make up this emerging and exciting new sector
Red Light Holland Places First Order for Psychedelic Truffles Microdosing Packs
Red Light Holland places 10,000-unit order of its psychedelic truffles for distribution in the Netherlands.
MagicMed Industries Inc. Announces Brokered Private Placement with Mackie Research Capital Corporation
MagicMed Industries is seeking to raise CAD$1.5 million via the sale of 6,000,000 common shares.
Psychedelic Drugs and Seniors Health
Seniors are now the fastest-growing demographic of cannabis consumers. This same pattern may play out as psychedelic drugs are legalized and commercialized.
Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute
Mydecine's recent acquisition, NeuroPharm Inc, is about to commence clinical trials using psilocybin to treat PTSD.
Why Psychedelics Microdosing Applications Have The Inside Track On Commercialization
Microdose-based psychedelic drug therapies have several advantages , ranging from R&D and drug licensing all the way through to drug commercialization and market penetration. It all adds up to greater profit potential.
PharmaDrug Inc. Proposes a Strategic Mutual Investment with Red Light Holland Corp.
PharmaDrug (CAN:BUZZ / US:LMLLF) and Red Light Holland (CAN:TRIP) have entered into a share exchange agreement.
Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc
This release confirms Mydecine's June 10th announcement of the acquisition of NeuroPharm Inc.
Novamind Announces Closing of Oversubscribed Private Placement
NovaMind closes on a CAD$4.4 million financing, upsized from the original CAD$3.0 million placement.
Psychedelic Drugs: the $16 TRILLION Opportunity?
A 2018 report estimates that mental health issues could cost the global economy $16 trillion between now and 2030. Psychedelic drugs are needed to mitigate those costs.
Champignon Provides Corporate Update
Champignon provides an update on its current trading halt and other corporate matters.
MagicMed Industries Files First Psychedelic Derivative Patent
MagicMed files with the USPTO with respect to its "broad portfolio of novel psilocybin molecular derivatives, the Psybrary™".